Cerebral is under investigation for possible violations of the Controlled Substances Act as the digital mental health company faces increasing scrutiny over its prescribing practices for medications like Adderall.
As first reported by Insider, Cerebral confirmed it had received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York on the evening of May 4. That...
Less than a week ago, Peloton announced it would have a treadmill back on the market by the end of August, following a May recall of its Tread+ and Tread due to a slew of reported injuries and one child death associated with the fitness equipment.
However, an SEC document reveals that connected fitness device company Pelton’s woes are far from over.
The Department of Justice and the U.S....
San Francisco-based EHR developer Practice Fusion has agreed to pay $145 million alongside an admission that it “solicited and received kickbacks from a major opioid company” in exchange for clinical decision support (CDS) alerts promoting unnecessary prescription opioids, according to a release from the US Department of Justice.
In a settlement announced yesterday (and hinted at in an earnings...
Outcome Health the entity may be nearing the end of its legal woes, but some of the individuals wrapped up in the company’s ad scandal aren’t quite out of the woods yet.
A recently unsealed criminal indictment filed in the Northern District of Illinois outlines charges against former CEO and cofounder Rishi Shah, former president and cofounder Shradha Agarwal, former CFO Brad Purdy and former EVP...
Roughly two years after the fact, digital healthcare advertiser Outcome Health is finally closing the loop on its ad fraud scandal. Yesterday the Chicago-based company and the US Department of Justice announced a $70 million settlement alongside an admission that the company’s former executives and employees sold falsified advertising inventory from 2012 to 2017.
“Outcome Health deceived its...
Help from above. The Department of Justice has taken the side of tech-enabled insurer Oscar Health in a federal antitrust suit it filed in November of last year against Florida Blue, Crain’s New York Business reports. While Oscar’s motion for a temporary injunction was rejected by a federal judge back in February, the DOJ filed a statement in April arguing that Florida Blue had incorrectly...
